source
- Intellia's in-body CRISPR therapy achieves first Phase 3 successIntellia announced that its experimental in vivo CRISPR gene‑editing therapy has completed a Phase 3 trial with positive results. This is the first instance of a CRISPR‑based treatment delivered d…
- Sun Pharma to acquire Organon for $11.75 billion in all-cash dealIndian pharmaceutical company Sun Pharma announced it will purchase Organon, a company focused on women's health and biosimilars that was spun out of Merck in 2021. The transaction is an all-cash…